Trial Profile
Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis: Double-blind Controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Periodontitis
- Focus Therapeutic Use
- 07 Jul 2014 New trial record